ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p477.xmlOpen Notes Are Here: Are We Ready?2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p477.pdf2021-08-25Open Notes Are Here: Are We Ready?https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p478.xmlClinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p478.pdf2021-08-25Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinibhttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p484.xmlNCCN Guidelines® Insights: Breast Cancer, Version 4.20212021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p484.pdf2021-08-25NCCN Guidelines® Insights: Breast Cancer, Version 4.2021https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p541.xmlHepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p541.pdf2021-08-25Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p577.xmlLeveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here?2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-p577.pdf2021-08-25Leveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here?https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxix.xmlNCCN Guidelines® Updates: Hepatobiliary Cancers2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxix.pdf2021-08-25NCCN Guidelines® Updates: Hepatobiliary Cancershttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxviii.xmlHighlights of the NCCN Oncology Research Program2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxviii.pdf2021-08-25Highlights of the NCCN Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxxi.xmlNCCN News2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxxi.pdf2021-08-25NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxxviii_1.xmlLetter to the Editor: T1a 0- to 2-cm Small Renal Masses2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxxviii_1.pdf2021-08-25Letter to the Editor: T1a 0- to 2-cm Small Renal Masseshttps://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxxviii_2.xmlAuthors’ Reply: To Letter to the Editor by Guo and Liu2021-06-15https://harbor.dev.pubfactory.com/view/journals/jnccn/19/5/article-pxxviii_2.pdf2021-08-25Authors’ Reply: To Letter to the Editor by Guo and Liu